<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">CEFADROXIL</span><br/>(sef-a-drox'ill)<br/><span class="topboxtradename">Duricef, </span><span class="topboxtradename">Ultracef<br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">antibiotic</span>; <span class="classification">first-generation cephalosporin</span><br/><b>Prototype: </b>Cefazolin<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>500 mg capsules; 1 g tablets; 125 mg/5 mL, 250 mg/5 mL, 500 mg/5 mL suspension</p>
<h1><a name="action">Actions</a></h1>
<p>Semisynthetic, first-generation cephalosporin antibiotic with antibacterial spectrum similar to that of cefazolin. Bactericidal
         action (similar to that of penicillins): drug penetrates bacterial cell wall, resists beta-lactamases and inactivates enzymes
         essential to cell wall synthesis. At equivalent doses, reportedly attains greater concentrations in serum and urine than other
         oral cephalosporins.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Active against organisms that liberate cephalosporinase and penicillinase (beta-lactamases). According to clinical and laboratory
         evidence, partial cross-allergenicity exists between penicillins and cephalosporins. Effective in reducing signs and symptoms
         of urinary tract infections, bone and joint infections, skin and soft tissue infections, and pharyngitis.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Primarily in treatment of urinary tract infections caused by <i>Escherichia coli, Proteus mirabilis,</i> and <i>Klebsiella</i> sp; infections of skin and skin structures caused by <i>Staphylococci</i> and <i>Streptococci;</i> and for treatment of group A beta-hemolytic streptococcal pharyngitis and tonsillitis.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to cephalosporins and related antibiotics; pregnancy (category B), lactation.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Sensitivity to penicillins or other drug allergies; impaired renal function, history of colitis.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Uncomplicated Urinary Tract Infection</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 12 g/d in 12 divided doses<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 30 mg/kg/d in 2 divided doses<br/><br/><span class="indicationtitle">Skin and Skin Structure Infections, Streptococcal Pharyngitis, or Tonsillitis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1 g/d in 12 divided doses<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 30 mg/kg/d in 2 divided doses<br/><br/><span class="impairmenttitle">Adjustment for Renal Impairment</span><br/>Cl<sub>cr</sub> <span class="rdage">Adult:</span> <span class="rdroute">PO</span> 1 g q24h<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 15 mg/kg q24h<br/><br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with food or milk to reduce nausea. If nausea persists, termination of therapy may be necessary.</li>
<li>Follow directions for mixing oral suspension found on drug label. Reconstituted suspension contains 125 mg or 250 mg cefadroxil
            per 5 mL.
         </li>
<li>Shake suspension well before use; discard after 14 d.</li>
<li>Store in tight container unless otherwise directed. Oral suspensions are stable for 14 d under refrigeration at 2°8°
            C (36°46° F). Avoid freezing. Note expiration date on label.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> Body as a Whole:</span> Hypersensitivity [Rash, swollen eyelids (<span class="speceff-life">angioedema</span>), pruritus, chills], superinfections. <span class="typehead">GI:</span> Nausea, <span class="speceff-common">diarrhea,</span> vomiting, heartburn, gastritis, bloating, abdominal cramps. 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>False-positive <span class="alt">urine glucose</span> determinations using <span class="alt">copper sulfate reduction reagents,</span> such as <span class="alt">Clinitest</span> or <span class="alt">Benedict's reagent,</span> but not with <span class="alt">glucose oxidase tests,</span> e.g., <span class="alt">Clinistix,</span>
<span class="alt">Diastix,</span>
<span class="alt">TesTape.</span>
<span class="alt">Cefadroxil-induced positive direct Coombs' test</span> may interfere with <span class="alt">cross-matching procedures</span> and <span class="alt">hematologic studies.</span>
</p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Probenecid</b> decreases renal excretion of cefadroxil. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Acid stable; rapidly absorbed from GI tract. <span class="typehead">Peak:</span> 1 h. <span class="typehead">Elimination:</span> 90% excreted unchanged in urine within 8 h; bacterial inhibitory levels persist 2022 h; crosses placenta; excreted
      in breast milk. <span class="typehead">Half-Life:</span> 112 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Determine previous hypersensitivity to cephalosporins, penicillins, and other drug allergies, before therapy is initiated.</li>
<li>Lab tests: Perform culture and sensitivity testing prior to and periodically during therapy.</li>
<li>Lab tests: Perform baseline and periodic renal function studies in patients with renal function impairment, and monitor I&amp;O
            ratio and pattern.
         </li>
<li>Monitor for manifestations of drug hypersensitivity (see Signs &amp; Symptoms, Appendix F). Discontinue drug and promptly report
            them if they appear.
         </li>
<li>Monitor for manifestations of superinfection (see Signs &amp; Symptoms, Appendix F). Promptly report their appearance.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Report promptly the onset of rash, urticaria, pruritus, or fever, as the possibility of an allergic reaction is high, if you
            are allergic to penicillin.
         </li>
<li>Take medication for the full course of therapy as directed by your physician.</li>
<li>Report promptly S&amp;S of superinfections (see Appendix F).</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>